Interleukin-1 in multiple myeloma: Producer cells and their role in the control of IL-6 production

British Journal of Haematology

Volumn 103, Issue 4, 1998, Pages 1152-1160

  Costes, Valérie ^a   Portier, Marielle ^a   Lu, Zhao Yang ^b   Rossi, Jean Francois ^c   Bataille, Régis ^d   Klein, Bernard ^a,b  

^a INSERM   (France)

^b HÔPITAL SAINT ELOI   (France)

^c LAPEYRONIE HOSPITAL   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

IL 1; IL 6; Multiple myeloma; PGE2; Plasma cells

Indexed keywords

INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION;

ADULT; AGED; CELL DIVISION; DINOPROSTONE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTERLEUKIN-6; MEGAKARYOCYTES; MIDDLE AGED; MULTIPLE MYELOMA; PLASMA CELLS; RECEPTORS, INTERLEUKIN-1;

EID: 0032428364     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01101.x     Document Type: Article

References (41)

1. Bataille, R., Barlogie, B., Lu, Z.Y., Rossi, J.F., Lavabre-Bertrand, T., Beck, T., Wijdenes, J., Brochier, J. & Klein, B. (1995) Biologic effects of anti-interleukin-6 (IL-6) murine monoclonal antibody in advanced multiple myeloma. Blood, 86, 685-691.
2. Bataille, R., Boccadoro, M. Klein, B., Durie, B. & Pileri, A. (1992) C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood, 80, 733-737.
3. Bataille, R. & Harousseau, J.L. (1997) Multiple myeloma. New England Journal of Medicine, 336, 1657-1664.
4. Bataille, R., Jourdan, M., Zhang, X.G. & Klein, B. (1989) Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. Journal of Clinical Investigation, 84, 2008-2011.
5. Borset, M., Helseth, E., Naume, B. & Waage, A. (1993) Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation. British Journal of Haematology, 85, 446-451.
6. Carter, A., Merchav, S., Silvian-Draxler, I. & Tatarsky, I. (1990) The role of interleukin-1 and tumor necrosis factor-α in human multiple myeloma. British Journal of Haematology, 74, 424-431.
7. Cozzolino, F., Torcia, M. Aldinucci, D., Rubartelli, A., Miliani, A., Shaw, A.R., Lansdorp, P.M. & Di Guglielmo, R. (1989) Production of interleukin-1 by bone marrow myeloma cells. Blood, 74, 380-387.
8. Degrassi, A., Hibert, D.M., Rudikoff, S., Anderson, A.O., Potter, M. & Coon, H.G. (1993) In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proceedings of the National Academy of Sciences of the United States of America, 90, 2060-2064.
9. Dinarello, C.A. (1991) Interleukin-1 and interleukin-1 antagonism. Blood, 77, 1627-1652.
10. Dinarello, C.A. (1996) Biologic basis for interleukin-1 in disease. Blood, 87, 2095-2147.
11. Donovan, K.A., Lacy, M.Q., Kline, M.P., Ahmann, G.J., Heimbach, J.K., Kyle, R.A. & Lust, J.A. (1998) Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma. Leukemia, 12, 593-600.
12. Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H. & Epstein, J. (1994) Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood, 84, 3063-3070.
13. Hata, H., Xiao, H., Petrucci, M.T., Woodliff, J., Chang, R. & Epstein, J. (1993) Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood, 81, 3357-3364.
14. Helle, M., Boeise, L. & Aarden, L.A. (1988) Functional discrimination between interleukin-6 and interleukin-1. European Journal of Immunology, 18, 1535.
15. Hermann, F., Andreef, M., Gruss, H.J., Brach, M.A., Lübbert, M. & Mertelsmann, R. (1991) Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression. Blood, 78, 2070-2074.
16. Hilbert, D.M., Kopf, M., Mock, B.A., Kohler, G. & Rudikoff, S. (1995) Interleukin 6 is essential for in vivo development of B lineage neoplasms. Journal of Experimental Medicine, 182, 243-248.
17. Hinson, R.M., Williams, J.A. & Shacter, E. (1996) Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proceedings of the National Academy of Sciences of the United States of America, 93, 4885-4890.
18. Jourdan, M., Zhang, X.G., Portier, M., Boiron, J.M., Bataille, R. & Klein, B. (1991) IFN-alpha induced autocrine production of IL-6 in myeloma cell lines. Journal of Immunology, 147, 4402-4407.
19. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoka, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A. & Kishimoto, T. (1988) Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myeloma. Nature, 332, 83-85.
20. Kawano, M., Tanaka, H., Ishikawa, H., Nobuyoshi, M., Iwato, K., Asaoku, H., Tanabe, O. & Kuramoto, A. (1989a) Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood, 73, 2145-2148.
21. Kawano, M. Yamamoto, I., Iwato, K., Tanaka, H., Asaoku, H., Tanabe, O., Ishikawa, H., Nobuyoshi, M., Ohmoto, Y. & Hirai, Y. (1989b) Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma. Blood, 73, 1646-1649.
22. Klein, B., Wijdenes, J., Zhang, X.G., Jourdan, M., Boiron, J.M., Liautard, J., Merlin, M., Clement, C., Morel-Fournier, B., Lu, Z.Y., Mannoni, P., Sany, J. & Bataille, R. (1991) Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood, 78, 1198-1204.
23. Klein, B., Zhang, X.G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M. & Bataille, R. (1989) Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
24. Klein, B., Zhang, X.G. & Rossi, J.F. (1998) Cytokine, cytokine receptors and signal transduction in human multiple myeloma. Myeloma, Biology and Management (ed. by J. S. Malpas, D. E. Bergsagel, R. A. Kyle and K. C. Anderson), p. 70. Oxford University Press.
25. Lattanzio, G., Libert, C., Aquilina, M., Cappelletti, M., Ciliberto, G., Musiani, P. & Poli, V. (1997) Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. American Journal of Pathology, 151, 689-696.
26. Leger Ravet, M.B., Peuchmaur, M., Devergne, O., Audouin, J., Raphael, M., Van Damme, J., Galanaud, P., Diebold, J. & Emilie, D. (1991) Interleukin-6 gene expression in Castleman's disease. Blood, 78, 2923-2930.
27. Levy, Y., Tsapis, A. & Brouet, J.C. (1991) Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. Journal of Clinical Investigation, 88, 696-699.
28. Lokhorst, H.M., Lamme, T., de Smet, M., Klein, S., de Weger, R.A., van Oers, R. & Bloem, A.C. (1994) Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84, 2269-2277.
29. Lu, Z.Y., Brailly, H., Wijdenes, J., Bataille, R., Rossi, J.F. & Klein, B. (1995) Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments. Blood, 86, 3123-3131.
30. Ludwig, H., Nachbaur, D.M., Fritz, E., Krainer, M. & Huber, H. (1991) Interleukin-6 is a prognostic factor in multiple myeloma. (Letter). Blood, 77, 2794-2795.
31. Marucha, P.T., Zeff, R.A. & Kreutzer, D.L. (1991) Cytokine-induced IL-1 beta gene expression in the human polymorphonuclear leukocyte: transcriptional and post-transcriptional regulation by tumor necrosis factor and IL-1. Journal of Immunology, 147, 2603-2608.
32. Portier, M., Rajzbaum, G., Zhang, X.G., Attal, M., Rusalen, C., Wijdenes, J., Mannoni, P., Maraninchi, D., Piechaczyk, M., Bataille, R. & Klein, B. (1991) In vivo interleukin-6 gene expression in the tumoral environment in multiple myeloma. European Journal of Immunology, 21, 1759-1762.
33. Portier, M., Zhang, X.G., Ursule, E., Lees, D., Jourdan, M., Bataille, R. & Klein, B. (1993) Cytokine gene expression in human multiple myeloma. British Journal of Haematology, 85, 514-520.
34. Potter, M., Wax, J.S., Anderson, A.O. & Nordan, R.P. (1985) Inhibition of plasmacytoma development in BALB/c mice by indomethacin. Journal of Experimental Medicine, 161, 996-1012.
35. Ray, K.P., Farrow, S., Daly, M., Talabot, F. & Searle, N. (1997) Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. Biochemical Journal, 328, 707-715.
36. Schwab, G., Siegall, C.B., Aarden, L.A., Neckers, L.M. & Nordan, R.P. (1991) Characterization of an interleukin-6-mediated autocrine loop in the human multiple myeloma cell line U266. Blood, 77, 587-595.
37. Torcia, M., Lucibello, M., Vannier, E., Fabiani, S., Miliani, A., Guidi, G., Spada, O., Dower, S.K., Sims, J.E., Shaw, A.R., Dinarello, C.A., Garaci, E. & Cozzolino, F. (1996) Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors. Experimental Hematology, 24, 868-874.
38. Tosato, G. & Jones, K.D. (1940) Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood, 75, 1305-1310.
39. Uchiyama, H., Barut, B.A., Mohrbacher, A.F., Chauhan, D. & Anderson, K.C. (1993) Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood, 82, 3712-3720.
40. Vesole, D.H., Tricot, G., Jagannath, S., Desikan, K.R., Siegel, D., Bracy, D., Miller, L., Cheson, B., Crowley, J. & Barlogie, B. (1996) Autotransplants in multiple myeloma: what have we learned? Blood, 88, 838-847.
41. Zhang, X.G., Bataille, R., Jourdan, M., Saeland, S., Banchereau, J., Mannoni, P. & Klein, B. (1990) Granulocyte-macrophage colony stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood, 76, 2599-2605.